Across America, millions rely on life-saving medication to manage chronic illnesses. But for many, these essential drugs are becoming increasingly out of reach. Why? Because Big Pharma, in its insatiable pursuit of profit, is jacking up prices at a staggering rate, leaving patients with a stark choice: their health or their financial well-being.

The soaring costs of prescription drugs in the United States have become a major concern for millions of Americans. The debate over pharmaceutical pricing has intensified as healthcare expenses continue to rise. One of the key players in this debate is the pharmaceutical industry, often called “Big Pharma.” Big Pharma has consistently argued against price negotiations, claiming it would stifle innovation and limit patient access to cutting-edge treatments. However, there is a growing skepticism among the public and policymakers about the credibility of these arguments.